10 20 30 40 50 60 70 80 1AJ7 - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER IMMUNOGLOBULIN 15-MAY-97 1AJ7
TITLE IMMUNOGLOBULIN 48G7 GERMLINE FAB ANTIBODY COMPLEXED WITH TITLE 2 HAPTEN 5-(PARA-NITROPHENYL PHOSPHONATE)-PENTANOIC ACID. TITLE 3 AFFINITY MATURATION OF AN ESTEROLYTIC ANTIBODY
COMPND MOL_ID: 1; COMPND 2 MOLECULE: IMMUNOGLOBULIN 48G7 FAB (LIGHT CHAIN); COMPND 3 CHAIN: L; COMPND 4 FRAGMENT: VARIABLE DOMAINS OF LIGHT AND HEAVY CHAINS AND COMPND 5 CONSTANT DOMAINS OF LIGHT AND HEAVY CHAINS; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: IMMUNOGLOBULIN 48G7 FAB (HEAVY CHAIN); COMPND 9 CHAIN: H; COMPND 10 FRAGMENT: VARIABLE DOMAINS OF LIGHT AND HEAVY CHAINS AND COMPND 11 CONSTANT DOMAINS OF LIGHT AND HEAVY CHAINS; COMPND 12 ENGINEERED: YES
SOURCE MOL_ID: 1; SOURCE 2 FRAGMENT: CONSTANT DOMAINS OF LIGHT AND HEAVY CHAINS; SOURCE 3 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 4 ORGANISM_COMMON: HOUSE MOUSE; SOURCE 5 ORGANISM_TAXID: 10090; SOURCE 6 CELL_LINE: 48G7; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PSAL143; SOURCE 11 OTHER_DETAILS: EACH CHAIN IS A FUSION POLYPEPTIDE WHICH IS SOURCE 12 PART HUMAN AND PART MOUSE; SOURCE 13 MOL_ID: 2; SOURCE 14 FRAGMENT: CONSTANT DOMAINS OF LIGHT AND HEAVY CHAINS; SOURCE 15 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 16 ORGANISM_COMMON: HUMAN; SOURCE 17 ORGANISM_TAXID: 9606; SOURCE 18 CELL_LINE: 48G7; SOURCE 19 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 20 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 21 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 22 EXPRESSION_SYSTEM_PLASMID: PSAL143; SOURCE 23 OTHER_DETAILS: EACH CHAIN IS A FUSION POLYPEPTIDE WHICH IS SOURCE 24 PART HUMAN AND PART MOUSE
KEYWDS GERMLINE ANTIBODY, FAB, CATALYTIC ANTIBODY, AFFINITY KEYWDS 2 MATURATION, IMMUNOGLOBULIN
EXPDTA X-RAY DIFFRACTION
AUTHOR G.J.WEDEMAYER,L.H.WANG,P.A.PATTEN,P.G.SCHULTZ,R.C.STEVENS
REVDAT 2 24-FEB-09 1AJ7 1 VERSN REVDAT 1 12-NOV-97 1AJ7 0
JRNL AUTH G.J.WEDEMAYER,P.A.PATTEN,L.H.WANG,P.G.SCHULTZ, JRNL AUTH 2 R.C.STEVENS JRNL TITL STRUCTURAL INSIGHTS INTO THE EVOLUTION OF AN JRNL TITL 2 ANTIBODY COMBINING SITE. JRNL REF SCIENCE V. 276 1665 1997 JRNL REFN ISSN 0036-8075 JRNL PMID 9180069 JRNL DOI 10.1126/SCIENCE.276.5319.1665
REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH G.J.WEDEMAYER,L.H.WANG,P.A.PATTEN,P.G.SCHULTZ, REMARK 1 AUTH 2 R.C.STEVENS REMARK 1 TITL CRYSTAL STRUCTURES OF THE FREE AND LIGANDED FORM REMARK 1 TITL 2 OF AN ESTEROLYTIC CATALYTIC ANTIBODY REMARK 1 REF J.MOL.BIOL. V. 268 390 1997 REMARK 1 REFN ISSN 0022-2836 REMARK 1 REFERENCE 2 REMARK 1 AUTH P.A.PATTEN,N.S.GRAY,P.L.YANG,C.B.MARKS, REMARK 1 AUTH 2 G.J.WEDEMAYER,J.J.BONIFACE,R.C.STEVENS,P.G.SCHULTZ REMARK 1 TITL THE IMMUNOLOGICAL EVOLUTION OF CATALYSIS REMARK 1 REF SCIENCE V. 271 1086 1996 REMARK 1 REFN ISSN 0036-8075 REMARK 1 REFERENCE 3 REMARK 1 AUTH S.A.LESLEY,P.A.PATTEN,P.G.SCHULTZ REMARK 1 TITL A GENETIC APPROACH TO THE GENERATION OF ANTIBODIES REMARK 1 TITL 2 WITH ENHANCED CATALYTIC ACTIVITIES REMARK 1 REF PROC.NATL.ACAD.SCI.USA V. 90 1160 1993 REMARK 1 REFN ISSN 0027-8424
REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.8 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.5 REMARK 3 NUMBER OF REFLECTIONS : 23005 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.217 REMARK 3 FREE R VALUE : 0.258 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.000 REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 60 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.10 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.11 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 339 REMARK 3 BIN R VALUE (WORKING SET) : 0.2330 REMARK 3 BIN FREE R VALUE : 0.2860 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 10.00 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 35 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4035 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 32 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.54 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4 REMARK 4 1AJ7 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : MAY-96 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL7-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.08 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23005 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 3.500 REMARK 200 R MERGE (I) : 0.06900 REMARK 200 R SYM (I) : 0.06900 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 15.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.17 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.1 REMARK 200 DATA REDUNDANCY IN SHELL : 3.50 REMARK 200 R MERGE FOR SHELL (I) : 0.20400 REMARK 200 R SYM FOR SHELL (I) : 0.20400 REMARK 200 <I/SIGMA(I)> FOR SHELL : 5.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1GAF REMARK 200 REMARK 200 REMARK: NULL
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.29 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.13 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 10-15 MG/ML FAB IN 100MM NACL, 10MM REMARK 280 TRIS PH 8.0, 1MM METHIONINE, 1MM SODIUM AZIDE, 0.5 MM EDTA.
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 30.45000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4310 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19270 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -22.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: L, H REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 OE2 GLU H 42 CG PRO H 213 2645 1.60 REMARK 500 OE1 GLU H 42 CB PRO H 213 2645 1.93 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA L 51 -41.17 71.99 REMARK 500 ASN L 152 -6.89 73.60 REMARK 500 ARG L 211 93.77 -68.20 REMARK 500 ILE H 29 -37.48 -37.00 REMARK 500 THR H 32 161.09 69.74 REMARK 500 TYR H 33 104.21 62.78 REMARK 500 LYS H 66 -36.45 -131.78 REMARK 500 ALA H 91 -175.17 -171.08 REMARK 500 TYR H 99 -3.04 69.33 REMARK 500 SER H 128 -72.16 -21.67 REMARK 500 PRO H 147 -155.95 -94.29 REMARK 500 REMARK 500 REMARK: NULL
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NPE H 217
DBREF 1AJ7 L 1 214 GB 4768677 AAD29608 23 236 DBREF 1AJ7 H 114 216 UNP P01857 IGHG1_HUMAN 1 103
SEQADV 1AJ7 LEU L 15 GB 4768677 VAL 37 CONFLICT SEQADV 1AJ7 GLU L 17 GB 4768677 ASP 39 CONFLICT SEQADV 1AJ7 SER L 20 GB 4768677 THR 42 CONFLICT SEQADV 1AJ7 LEU L 21 GB 4768677 ILE 43 CONFLICT SEQADV 1AJ7 ARG L 24 GB 4768677 GLN 46 CONFLICT SEQADV 1AJ7 GLU L 28 GB 4768677 ASP 50 CONFLICT SEQADV 1AJ7 SER L 30 GB 4768677 ASN 52 CONFLICT SEQADV 1AJ7 GLY L 31 GB 4768677 ASN 53 CONFLICT SEQADV 1AJ7 SER L 34 GB 4768677 ASN 56 CONFLICT SEQADV 1AJ7 LEU L 36 GB 4768677 TYR 58 CONFLICT SEQADV 1AJ7 ASP L 41 GB 4768677 GLY 63 CONFLICT SEQADV 1AJ7 GLY L 42 GB 4768677 LYS 64 CONFLICT SEQADV 1AJ7 ILE L 44 GB 4768677 PRO 66 CONFLICT SEQADV 1AJ7 ARG L 46 GB 4768677 LEU 68 CONFLICT SEQADV 1AJ7 ALA L 50 GB 4768677 GLY 72 CONFLICT SEQADV 1AJ7 THR L 53 GB 4768677 ASN 75 CONFLICT SEQADV 1AJ7 ASP L 55 GB 4768677 GLU 77 CONFLICT SEQADV 1AJ7 SER L 56 GB 4768677 THR 78 CONFLICT SEQADV 1AJ7 LYS L 60 GB 4768677 SER 82 CONFLICT SEQADV 1AJ7 ARG L 66 GB 4768677 GLY 88 CONFLICT SEQADV 1AJ7 SER L 69 GB 4768677 THR 91 CONFLICT SEQADV 1AJ7 TYR L 71 GB 4768677 PHE 93 CONFLICT SEQADV 1AJ7 SER L 72 GB 4768677 ILE 94 CONFLICT SEQADV 1AJ7 LEU L 73 GB 4768677 PHE 95 CONFLICT SEQADV 1AJ7 GLU L 79 GB 4768677 GLN 101 CONFLICT SEQADV 1AJ7 SER L 80 GB 4768677 PRO 102 CONFLICT SEQADV 1AJ7 PHE L 83 GB 4768677 ILE 105 CONFLICT SEQADV 1AJ7 ASP L 85 GB 4768677 THR 107 CONFLICT SEQADV 1AJ7 LEU L 89 GB 4768677 GLN 111 CONFLICT SEQADV 1AJ7 ALA L 92 GB 4768677 ASP 114 CONFLICT SEQADV 1AJ7 SER L 93 GB 4768677 ASN 115 CONFLICT SEQADV 1AJ7 TYR L 94 GB 4768677 LEU 116 CONFLICT SEQADV 1AJ7 ARG L 96 GB 4768677 LEU 118 CONFLICT SEQADV 1AJ7 SER L 177 GB 4768677 ASN 199 CONFLICT
SEQRES 1 L 214 ASP ILE GLN MET THR GLN SER PRO SER SER LEU SER ALA SEQRES 2 L 214 SER LEU GLY GLU ARG VAL SER LEU THR CYS ARG ALA SER SEQRES 3 L 214 GLN GLU ILE SER GLY TYR LEU SER TRP LEU GLN GLN LYS SEQRES 4 L 214 PRO ASP GLY THR ILE LYS ARG LEU ILE TYR ALA ALA SER SEQRES 5 L 214 THR LEU ASP SER GLY VAL PRO LYS ARG PHE SER GLY SER SEQRES 6 L 214 ARG SER GLY SER ASP TYR SER LEU THR ILE SER SER LEU SEQRES 7 L 214 GLU SER GLU ASP PHE ALA ASP TYR TYR CYS LEU GLN TYR SEQRES 8 L 214 ALA SER TYR PRO ARG THR PHE GLY GLY GLY THR LYS VAL SEQRES 9 L 214 GLU ILE LYS ARG THR VAL ALA ALA PRO SER VAL PHE ILE SEQRES 10 L 214 PHE PRO PRO SER ASP GLU GLN LEU LYS SER GLY THR ALA SEQRES 11 L 214 SER VAL VAL CYS LEU LEU ASN ASN PHE TYR PRO ARG GLU SEQRES 12 L 214 ALA LYS VAL GLN TRP LYS VAL ASP ASN ALA LEU GLN SER SEQRES 13 L 214 GLY ASN SER GLN GLU SER VAL THR GLU GLN ASP SER LYS SEQRES 14 L 214 ASP SER THR TYR SER LEU SER SER THR LEU THR LEU SER SEQRES 15 L 214 LYS ALA ASP TYR GLU LYS HIS LYS VAL TYR ALA CYS GLU SEQRES 16 L 214 VAL THR HIS GLN GLY LEU SER SER PRO VAL THR LYS SER SEQRES 17 L 214 PHE ASN ARG GLY GLU CYS SEQRES 1 H 217 GLN VAL GLN LEU GLN GLN SER GLY ALA GLU LEU VAL LYS SEQRES 2 H 217 PRO GLY ALA SER VAL LYS LEU SER CYS THR ALA SER GLY SEQRES 3 H 217 PHE ASN ILE LYS ASP THR TYR MET HIS TRP VAL LYS GLN SEQRES 4 H 217 ARG PRO GLU GLN GLY LEU GLU TRP ILE GLY ARG ILE ASP SEQRES 5 H 217 PRO ALA ASN GLY ASN THR LYS TYR ASP PRO LYS PHE GLN SEQRES 6 H 217 GLY LYS ALA THR ILE THR ALA ASP THR SER SER ASN THR SEQRES 7 H 217 ALA TYR LEU GLN LEU SER SER LEU THR SER GLU ASP THR SEQRES 8 H 217 ALA VAL TYR TYR CYS ALA SER TYR TYR GLY ILE TYR TRP SEQRES 9 H 217 GLY GLN GLY THR THR LEU THR VAL SER SER ALA SER THR SEQRES 10 H 217 LYS GLY PRO SER VAL PHE PRO LEU ALA PRO SER SER LYS SEQRES 11 H 217 SER THR SER GLY GLY THR ALA ALA LEU GLY CYS LEU VAL SEQRES 12 H 217 LYS ASP TYR PHE PRO GLU PRO VAL THR VAL SER TRP ASN SEQRES 13 H 217 SER GLY ALA LEU THR SER GLY VAL HIS THR PHE PRO ALA SEQRES 14 H 217 VAL LEU GLN SER SER GLY LEU TYR SER LEU SER SER VAL SEQRES 15 H 217 VAL THR VAL PRO SER SER SER LEU GLY THR GLN THR TYR SEQRES 16 H 217 ILE CYS ASN VAL ASN HIS LYS PRO SER ASN THR LYS VAL SEQRES 17 H 217 ASP LYS LYS VAL GLU PRO LYS SER CYS
HET NPE H 217 32
HETNAM NPE 5-(PARA-NITROPHENYL PHOSPHONATE)-PENTANOIC ACID
FORMUL 3 NPE C11 H13 N O7 P 1-
HELIX 1 1 SER L 80 ASP L 82 5 3 HELIX 2 2 ASP L 122 SER L 127 1 6 HELIX 3 3 LYS L 183 GLU L 187 1 5 HELIX 4 4 ILE H 29 ASP H 31 5 3 HELIX 5 5 PRO H 61 PHE H 63 5 3 HELIX 6 6 SER H 87 ASP H 89 5 3 HELIX 7 7 TYR H 98 GLY H 100 5 3 HELIX 8 8 ASN H 155 GLY H 157 5 3 HELIX 9 9 LYS H 201 SER H 203 5 3
SHEET 1 A 4 MET L 4 SER L 7 0 SHEET 2 A 4 VAL L 19 ALA L 25 -1 N ARG L 24 O THR L 5 SHEET 3 A 4 ASP L 70 ILE L 75 -1 N ILE L 75 O VAL L 19 SHEET 4 A 4 PHE L 62 SER L 67 -1 N SER L 67 O ASP L 70 SHEET 1 B 5 SER L 10 SER L 14 0 SHEET 2 B 5 THR L 102 LYS L 107 1 N LYS L 103 O LEU L 11 SHEET 3 B 5 ALA L 84 GLN L 90 -1 N TYR L 86 O THR L 102 SHEET 4 B 5 LEU L 33 GLN L 38 -1 N GLN L 38 O ASP L 85 SHEET 5 B 5 ILE L 44 ILE L 48 -1 N ILE L 48 O TRP L 35 SHEET 1 C 4 SER L 114 PHE L 118 0 SHEET 2 C 4 THR L 129 ASN L 137 -1 N ASN L 137 O SER L 114 SHEET 3 C 4 LEU L 175 SER L 182 -1 N LEU L 181 O ALA L 130 SHEET 4 C 4 SER L 159 VAL L 163 -1 N SER L 162 O SER L 176 SHEET 1 D 3 LYS L 145 VAL L 150 0 SHEET 2 D 3 VAL L 191 THR L 197 -1 N THR L 197 O LYS L 145 SHEET 3 D 3 VAL L 205 ASN L 210 -1 N PHE L 209 O TYR L 192 SHEET 1 E 4 GLN H 3 GLN H 6 0 SHEET 2 E 4 VAL H 18 SER H 25 -1 N SER H 25 O GLN H 3 SHEET 3 E 4 THR H 77 LEU H 82 -1 N LEU H 82 O VAL H 18 SHEET 4 E 4 ALA H 67 ASP H 72 -1 N ASP H 72 O THR H 77 SHEET 1 F 6 GLU H 10 VAL H 12 0 SHEET 2 F 6 THR H 107 VAL H 111 1 N THR H 110 O GLU H 10 SHEET 3 F 6 ALA H 91 ALA H 96 -1 N TYR H 93 O THR H 107 SHEET 4 F 6 MET H 34 GLN H 39 -1 N GLN H 39 O VAL H 92 SHEET 5 F 6 LEU H 45 ASP H 52 -1 N ILE H 51 O MET H 34 SHEET 6 F 6 ASN H 56 TYR H 59 -1 N LYS H 58 O ARG H 50 SHEET 1 G 4 SER H 120 LEU H 124 0 SHEET 2 G 4 THR H 135 TYR H 145 -1 N LYS H 143 O SER H 120 SHEET 3 G 4 TYR H 176 PRO H 185 -1 N VAL H 184 O ALA H 136 SHEET 4 G 4 VAL H 163 THR H 165 -1 N HIS H 164 O VAL H 181 SHEET 1 H 3 THR H 151 TRP H 154 0 SHEET 2 H 3 ILE H 195 HIS H 200 -1 N ASN H 199 O THR H 151 SHEET 3 H 3 THR H 205 LYS H 210 -1 N LYS H 209 O CYS H 196
SSBOND 1 CYS L 23 CYS L 88 1555 1555 2.03 SSBOND 2 CYS L 134 CYS L 194 1555 1555 2.03 SSBOND 3 CYS L 214 CYS H 216 1555 1555 2.03 SSBOND 4 CYS H 22 CYS H 95 1555 1555 2.03 SSBOND 5 CYS H 140 CYS H 196 1555 1555 2.03
CISPEP 1 SER L 7 PRO L 8 0 -0.72 CISPEP 2 TYR L 94 PRO L 95 0 0.05 CISPEP 3 TYR L 140 PRO L 141 0 -0.30 CISPEP 4 PHE H 146 PRO H 147 0 -1.16 CISPEP 5 GLU H 148 PRO H 149 0 -0.32
SITE 1 AC1 14 TYR H 33 HIS H 35 TRP H 47 ALA H 96 SITE 2 AC1 14 TYR H 98 TYR H 99 GLY H 100 TRP H 103 SITE 3 AC1 14 LEU L 89 TYR L 94 ARG L 96 PHE L 98 SITE 4 AC1 14 ARG L 211 GLU L 213
CRYST1 46.100 60.900 73.100 90.00 104.80 90.00 P 1 21 1 2
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.021692 0.000000 0.005731 0.00000
SCALE2 0.000000 0.016420 0.000000 0.00000
SCALE3 0.000000 0.000000 0.014149 0.00000